Pfizer Sees FY24 Adj. EPS $2.15-$2.35 Vs $2.76 Estimate
Portfolio Pulse from Benzinga Newsdesk
Pfizer has projected its adjusted earnings per share (EPS) for fiscal year 2024 to be in the range of $2.15 to $2.35, which is below the analyst estimate of $2.76.
May 01, 2024 | 10:49 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Pfizer's projected adjusted EPS for FY24 falls short of analyst expectations, indicating potential challenges ahead.
Pfizer's lower-than-expected earnings forecast for FY24 could lead to negative investor sentiment in the short term, potentially impacting the stock price negatively as it falls short of the market's expectations.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100